TY - JOUR T1 - Patients with interstitial lung disease and pulmonary sarcoidosis are at high risk for severe illness related to COVID-19 JF - Cleveland Clinic Journal of Medicine JO - Cleve Clin J Med DO - 10.3949/ccjm.87a.ccc026 AU - Brian Southern Y1 - 2020/05/14 UR - http://www.ccjm.org/content/early/2020/05/12/ccjm.87a.ccc026.abstract N2 - Analyses of COVID-19 patients with preexisting interstitial lung disease (ILD) or pulmonary sarcoidosis is lacking but registries are ongoing. Treatment of COVID-19 for patients with underlying ILD or sarcoidosis may include hospital admission, possible drug treatment, caution with steroids, and avoidance of mechanical ventilation in acute exacerbation of ILD. Patients with COVID-19 respiratory illness are at risk for developing ILD. ER -